MINT1526A (RG-7594) is a humanized IgG1 monoclonal antibody inhibitor targeting alpha5beta1 integrin, exhibiting significant anti-angiogenic activity. This compound is applicable in cancer research.
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted